Skip to main content
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Journals
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • Focus on Radiation Oncology
      • Novel Combinations
      • Reviews
      • Editors' Picks
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citation
    • Author/Keyword
  • News
    • Cancer Discovery News
Cancer Biology and Translational Studies

Identification of the Novel Role of CD24 as an Oncogenesis Regulator and Therapeutic Target for Triple-Negative Breast Cancer

Shih-Hsuan Chan, Kuo-Wang Tsai, Shu-Yi Chiu, Wen-Hung Kuo, Heng-Yi Chen, Shih Sheng Jiang, King-Jen Chang, Wen-Chun Hung and Lu-Hai Wang
Shih-Hsuan Chan
Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.Institute of Molecular and Medicine, National Tsing Hua University, Hsinchu, Taiwan.Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kuo-Wang Tsai
Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.Department of Chemical Biology, National Pingtung University of Education, Pingtung, Taiwan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shu-Yi Chiu
Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen-Hung Kuo
Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heng-Yi Chen
Graduate Institute of Life Sciences, National Defense Medical Center, Taipei, Taiwan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shih Sheng Jiang
National Institute of Cancer Research, National Health Research Institutes, Miaoli, Taiwan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
King-Jen Chang
Department of Surgery, Taiwan Adventist Hospital, Taipei, Taiwan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wen-Chun Hung
National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lu-Hai Wang
Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.Institute of Molecular and Medicine, National Tsing Hua University, Hsinchu, Taiwan.Institute of Molecular and Genomic Medicine, National Health Research Institutes, Miaoli, Taiwan.Chinese Medicine Research Center, China Medical University, Taichung, Taiwan.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lu-hai.wang@nhri.org.tw
DOI: 10.1158/1535-7163.MCT-18-0292 Published January 2019
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't.
PreviousNext
Back to top
Molecular Cancer Therapeutics: 18 (1)
January 2019
Volume 18, Issue 1
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of the Novel Role of CD24 as an Oncogenesis Regulator and Therapeutic Target for Triple-Negative Breast Cancer
(Your Name) has forwarded a page to you from Molecular Cancer Therapeutics
(Your Name) thought you would be interested in this article in Molecular Cancer Therapeutics.
Citation Tools
Identification of the Novel Role of CD24 as an Oncogenesis Regulator and Therapeutic Target for Triple-Negative Breast Cancer
Shih-Hsuan Chan, Kuo-Wang Tsai, Shu-Yi Chiu, Wen-Hung Kuo, Heng-Yi Chen, Shih Sheng Jiang, King-Jen Chang, Wen-Chun Hung and Lu-Hai Wang
Mol Cancer Ther January 1 2019 (18) (1) 147-161; DOI: 10.1158/1535-7163.MCT-18-0292

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Identification of the Novel Role of CD24 as an Oncogenesis Regulator and Therapeutic Target for Triple-Negative Breast Cancer
Shih-Hsuan Chan, Kuo-Wang Tsai, Shu-Yi Chiu, Wen-Hung Kuo, Heng-Yi Chen, Shih Sheng Jiang, King-Jen Chang, Wen-Chun Hung and Lu-Hai Wang
Mol Cancer Ther January 1 2019 (18) (1) 147-161; DOI: 10.1158/1535-7163.MCT-18-0292
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Targeted Therapies and Expression of their Targets
  • CCAT1 Promotes Prostate Cancer Cell Proliferation
  • TGFβ1/Integrin β3 in Acquired Resistance to EGFR TKIs
Show more Cancer Biology and Translational Studies
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About MCT

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2019 by the American Association for Cancer Research.

Molecular Cancer Therapeutics
eISSN: 1538-8514
ISSN: 1535-7163

Advertisement